Loading…
Based on limited metadata, this FDA Warning Letter was issued to Actavis Laboratories FL, Inc., a pharmaceutical manufacturer, on February 1, 2019. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA drug product regulations, though the issuing office is not specified in the metadata provided. Further review of the complete warning letter would be necessary to identify the particular compliance issues cited.